Enzyme-Triggered In Situ Assembly of Fe₃O₄ Nanozyme Synthesis Enables Portable Point-of-Care Detection of Acid...

Acid phosphatase (ACP) is a clinically important enzyme whose early-stage detection is hindered by its extremely low abundance, nonspecific tissue distribution, and rapid loss of activity under conventional analytical conditions. Herein, we present a target-driven in situ nanozyme synthesis strategy that enables rapid and ultrasensitive point-of-care testing (POCT) of ACP. In this approach, ACP catalyzes the hydrolysis of L-ascorbic acid 2-phosphate sesquimagnesium (AAPS), producing ascorbic acid (AA). The generated AA partially reduces Fe³⁺ ions to Fe²⁺, thereby initiating alkaline co-precipitation and in situ formation of Fe₃O₄ nanoparticles. Polyvinylpyrrolidone (PVP) stabilizes the nanoparticles and preserves catalytic accessibility, while their intrinsic magnetism allows for efficient magnetic separation to eliminate matrix interference. The resulting Fe₃O₄@PVP nanozymes display pronounced peroxidase-like activity, catalyzing hydrogen-peroxide-mediated oxidation of 3,3',5,5'-tetramethylbenzidine (TMB). Quantitative readout can be achieved using either spectrophotometric analysis or smartphone imaging. The sensing platform achieves a detection limit of 0.021 U/L within 40 min and demonstrates excellent sensitivity, selectivity, and operational robustness. Successful validation in human serum confirms its clinical feasibility, while smartphone-based imaging enables portable and low-cost quantification suitable for decentralized diagnostics. Collectively, this work establishes a generalizable paradigm for target-triggered nanozyme generation aimed at detecting low-abundance and labile biomarkers.